Table 3.
Survival analysis of Balb/c mice bearing CT.26.WT after treatment.
| Experimental Group Analysis | Overall Survival Rates | Kaplan–Meier | |
|---|---|---|---|
| Curative Subsection | % of Survivors on Day 55 after Tumor Inoculation | p | χ2 |
| Control | 0 | NA | NA |
| AP | 22.2 | 0.777 | 0.080 |
| AP + 5-FU | 87.5 | 0.000 | 11.206 |
| AG.1 | 50 | 0.065 | 3.404 |
| AG.1 + 5-FU | 33.3 | 0.018 | 5.512 |
| AP + AG.1 | 55.5 | 0.022 | 5.217 |
| AP + AG.1 + 5-FU | 50 | 0.001 | 10.288 |
| 5-FU | 77.7 | 0.002 | 8.948 |
| Preventive Subsection | % of Survivors on Day 45 after Tumor Inoculation | p | χ2 |
| AP | 100 | NA | NA |
| AG.1 | 100 | NA | NA |
AP, Agarikon Plus; AG.1, Agarikon.1; 5-FU, 5-fluorouracil; NA, not applicable, survival of control group based on literature.